K

Kiniksa Pharmaceuticals Ltd
D

KNSA

25.730
USD
-0.87
(-3.27%)
مغلق
حجم التداول
12,064
الربح لكل سهم
0
العائد الربحي
0
P/E
-147
حجم السوق
1,569,142,757
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALNY
    31.19
    (13.13%)
    268.66 USD
    B
    BGNE
    -4.190
    (-2.51%)
    162.540 USD
    B
    BLUE
    -0.06000
    (-5.26%)
    1.08000 USD
    C
    CRSP
    -2.450
    (-4.28%)
    54.840 USD
    E
    EDIT
    -0.28500
    (-5.26%)
    5.13500 USD
    N
    NKTX
    -0.03000
    (-0.47%)
    6.41000 USD
    S
    SGMO
    -0.09690
    (-12.11%)
    0.70340 USD
    V
    VYGR
    -0.59000
    (-6.37%)
    8.67000 USD
    X
    XNCR
    -0.600
    (-2.93%)
    19.880 USD
الأخبار
المقالات

العنوان: Kiniksa Pharmaceuticals International plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.